Detail
Článek
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Antimicrobial effect of commercial phage preparation Stafal® on biofilm and planktonic forms of methicillin-resistant Staphylococcus aureus

M. Dvořáčková, F. Růžička, M. Benešík, R. Pantůček, M. Dvořáková-Heroldová,

. 2019 ; 64 (1) : 121-126. [pub] 20180620

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc19021865

Grantová podpora
16-29916A Ministerstvo Zdravotnictví Ceské Republiky
NV16-29916A MZ0 CEP - Centrální evidence projektů

Staphylococcus aureus may be a highly virulent human pathogen, especially when it is able to form a biofilm, and it is resistant to antibiotic. Infections caused by these bacteria significantly affect morbidity and mortality, primarily in hospitalized patients. Treatment becomes more expensive, more toxic, and prolonged. This is the reason why research on alternative therapies should be one of the main priorities of medicine and biotechnology. A promising alternative treatment approach is bacteriophage therapy. The effect of the anti-staphylococcal bacteriophage preparation Stafal® on biofilm reduction was assessed on nine S. aureus strains using both sonication with subsequent quantification of surviving cells on the catheter surface and evaluation of biofilm reduction in microtiter plates. It was demonstrated that the bacteriophages destroy planktonic cells very effectively. However, to destroy cells embedded in the biofilm effectively requires a concentration at least ten times higher than that provided by the commercial preparation. The catheter disc method (CDM) allowed easier comparison of the effect on planktonic cells and cells in a biofilm than the microtiter plate (MTP) method.

000      
00000naa a2200000 a 4500
001      
bmc19021865
003      
CZ-PrNML
005      
20190607120846.0
007      
ta
008      
190607s2019 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s12223-018-0622-3 $2 doi
035    __
$a (PubMed)29923129
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Dvořáčková, Milada $u Department of Microbiology, Faculty of Medicine, Masaryk University and St. Anne's University Hospital, Pekařská 53, 656 91, Brno, Czech Republic.
245    10
$a Antimicrobial effect of commercial phage preparation Stafal® on biofilm and planktonic forms of methicillin-resistant Staphylococcus aureus / $c M. Dvořáčková, F. Růžička, M. Benešík, R. Pantůček, M. Dvořáková-Heroldová,
520    9_
$a Staphylococcus aureus may be a highly virulent human pathogen, especially when it is able to form a biofilm, and it is resistant to antibiotic. Infections caused by these bacteria significantly affect morbidity and mortality, primarily in hospitalized patients. Treatment becomes more expensive, more toxic, and prolonged. This is the reason why research on alternative therapies should be one of the main priorities of medicine and biotechnology. A promising alternative treatment approach is bacteriophage therapy. The effect of the anti-staphylococcal bacteriophage preparation Stafal® on biofilm reduction was assessed on nine S. aureus strains using both sonication with subsequent quantification of surviving cells on the catheter surface and evaluation of biofilm reduction in microtiter plates. It was demonstrated that the bacteriophages destroy planktonic cells very effectively. However, to destroy cells embedded in the biofilm effectively requires a concentration at least ten times higher than that provided by the commercial preparation. The catheter disc method (CDM) allowed easier comparison of the effect on planktonic cells and cells in a biofilm than the microtiter plate (MTP) method.
650    12
$a antiinfekční látky $7 D000890
650    _2
$a bakteriologické techniky $7 D001431
650    12
$a biofilmy $7 D018441
650    _2
$a počet mikrobiálních kolonií $7 D015169
650    _2
$a lidé $7 D006801
650    _2
$a methicilin rezistentní Staphylococcus aureus $x růst a vývoj $x izolace a purifikace $x virologie $7 D055624
650    _2
$a mikrobiální viabilita $7 D050296
650    _2
$a stafylokokové infekce $x mikrobiologie $7 D013203
650    _2
$a stafylokokové bakteriofágy $x fyziologie $7 D013204
650    _2
$a Staphylococcus aureus $x růst a vývoj $x izolace a purifikace $x virologie $7 D013211
655    _2
$a časopisecké články $7 D016428
700    1_
$a Růžička, Filip $u Department of Microbiology, Faculty of Medicine, Masaryk University and St. Anne's University Hospital, Pekařská 53, 656 91, Brno, Czech Republic. fruzic@fnusa.cz.
700    1_
$a Benešík, Martin $u Faculty of Science, Masaryk University, Kamenice 5, 625 00, Brno, Czech Republic.
700    1_
$a Pantůček, Roman $u Faculty of Science, Masaryk University, Kamenice 5, 625 00, Brno, Czech Republic.
700    1_
$a Dvořáková-Heroldová, Monika $u Department of Microbiology, Faculty of Medicine, Masaryk University and St. Anne's University Hospital, Pekařská 53, 656 91, Brno, Czech Republic.
773    0_
$w MED00011005 $t Folia microbiologica $x 1874-9356 $g Roč. 64, č. 1 (2019), s. 121-126
856    41
$u https://pubmed.ncbi.nlm.nih.gov/29923129 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20190607 $b ABA008
991    __
$a 20190607121025 $b ABA008
999    __
$a ok $b bmc $g 1413055 $s 1060220
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 64 $c 1 $d 121-126 $e 20180620 $i 1874-9356 $m Folia microbiologica $n Folia microbiol. (Prague) $x MED00011005
GRA    __
$a 16-29916A $p Ministerstvo Zdravotnictví Ceské Republiky
GRA    __
$a NV16-29916A $p MZ0
LZP    __
$a Pubmed-20190607

Najít záznam

Citační ukazatele

Nahrávání dat...

Možnosti archivace

Nahrávání dat...